OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Tina S. Morris, PhD, is vice president of Biologics & Biotechnology at United States Pharmacopeia (USP)
November 02, 2015
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
March 02, 2015
A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
September 02, 2012
USP optimizes identification tests and impurities procedures.
August 02, 2011
USP promotes horizontal standards for biologics' quality attributes.
October 02, 2009
USP workshop participants support new methods to safeguard heparin products but desire international harmonization. This article contains bonus online-exclusive material.
March 02, 2009
USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.